Busca avançada
Ano de início
Entree


Glycogen synthase kinase 3 inhibition enhances mineral nodule formation by cementoblasts in vitro

Texto completo
Autor(es):
Abdalla, Henrique ; Storino, Rafael ; Bandeira, Amanda ; Teixeira, Lucas ; Millas, Ana ; Lisboa-Filho, Paulo ; Kantovitz, Kamila ; Nociti Junior, Francisco
Número total de Autores: 8
Tipo de documento: Artigo Científico
Fonte: BRAZILIAN ORAL RESEARCH; v. 37, p. 10-pg., 2023-01-01.
Resumo

This study aimed to investigate whether GSK-3 inhibition (CHIR99021) effectively promoted mineralization by cementoblasts (OCCM- 30). OCCM-30 cells were used and treated with different concentrations of CHIR99021 (2.5, 5, and 10 mM). Experiments included proliferation and viability, cellular metabolic activity, gene expression, and mineral nodule formation by Xylene Orange at the experimental time points. In general, CHIR99021 did not significantly affect OCCM-30 viability and cell metabolism (MTT assay) (p > 0.05), but increased OCCM-30 proliferation at 2.5 mM on days 2 and 4 (p < 0.05). Data analysis further showed that inhibition of GSK-3 resulted in increased transcript levels of Axin2 in OCCM-30 cells starting as early as 4 h, and regulated the expression of key bone markers including alkaline phosphatase (Alp), runt-related transcription factor 2 (Runx-2), osteocalcin (Ocn), and osterix (Osx). In addition, CHIR99021 led to an enhanced mineral nodule formation in vitro under both osteogenic and non- osteogenic conditions as early as 5 days after treatment. Altogether, the results of the current study suggest that inhibition of GSK-3 has the potential to promote cementoblast differentiation leading to increased mineral deposition in vitro. (AU)

Processo FAPESP: 19/04276-7 - O uso de microagulhas revestíveis com fármacos para o controle de da dor e inflamação
Beneficiário:Henrique Ballassini Abdalla
Modalidade de apoio: Bolsas no Brasil - Pós-Doutorado
Processo FAPESP: 19/05274-8 - Bioimpressão 3D de enxertos vasculares e as biotintas utilizadas na aplicação
Beneficiário:Ana Luíza Garcia Millás Massaguer
Modalidade de apoio: Auxílio à Pesquisa - Pesquisa Inovativa em Pequenas Empresas - PIPE